Since then, many sellers have pivoted to personalized formulations that add ingredients such as vitamin B-12 and argue the result is not essentially a copy. But FDA said on April 1, 2026 that a compounded product combining semaglutide and another active ingredient such as vitamin B12 may still be essentially a copy unless a prescriber documents a patient-specific significant difference. In March 2026, Eli Lilly has warned against the practice of compounding tirzepatide with vitamin B-12
September 16, 2022
Adding community-based and treatment-focused strategies, including suicide prevention training throughout the organization coupled with identification, treatment, and care transition, Wellstar will continue strengthening the community
Both oral and injectable GLP-1 medications share a similar side effect profile because they act on the same receptor
"There's no doubt to me there's a definite shift in consumer demand based on GLP-1s." Among ideas floated in the restaurant association survey: Restaurants should add high-protein or GLP-1-friendly symbols to their menus the way they have for heart-healthy and vegan or vegetarian dishes
The global GLP-1 obesity home delivery injectables market is advancing rapidly, driven by the rising prevalence of obesity and the growing adoption of GLP-1 receptor agonists as long-term weight management therapies